With the help of Duane Morris partner Driscoll Ugarte, a New Jersey biopharmaceutical company will leap forward with its final phase of development for a new drug for cancer patients suffering from one of the most common side effects of treatment.
The Boca Raton attorney represented Soligenix Inc., which focuses on developing and commercializing drugs that treat rare diseases, in a $3 million deal with SciClone Pharmaceuticals Inc., a Foster City, California-based company that plans to introduce the treatment in Asia.
